DiaMedica Therapeutics (DMAC) Return on Sales (2018 - 2019)
DiaMedica Therapeutics (DMAC) has 2 years of Return on Sales data on record, last reported at 18.14% in Q2 2019.
- For Q2 2019, Return on Sales changed N/A year-over-year to 18.14%; the TTM value through Jun 2019 reached 18.14%, changed N/A, while the annual FY2024 figure was 718.94%, 16201.0% down from the prior year.
- Return on Sales reached 18.14% in Q2 2019 per DMAC's latest filing, down from 16.67% in the prior quarter.
- Across five years, Return on Sales topped out at 2.77% in Q3 2018 and bottomed at 18.14% in Q2 2019.